CFOTO | Future Publishing | Getty Images
Pfizer on Thursday he said so combination vaccine Candidates targeting Covid and influenza will move into late-stage testing in the coming months after showing positive initial results in an early to mid-stage study.
This excites the pharmaceutical giant and its German partner BioNTech a step closer to obtaining a possible regulatory approval for a combination vaccine for Covid and flu. Earlier this year, Pfizer said so hopes to start a vaccine targeting these two respiratory viruses in 2024 or later.
Pfizer and other vaccine makers such as Modern and Novavax we believe that combination shots will simplify the process for people to protect themselves against respiratory viruses that usually increase at the same time of year.
“This vaccine has the potential to reduce the impact of two respiratory diseases with a single injection and can simplify immunization practices,” said Annaliesa Anderson, head of vaccine research and development at Pfizer.
Pfizer CEO Albert Bourla said during an investor call earlier this month that he believes the convenience of combination vaccines will “unlock significant potential by improving vaccination rates.”
Covid vaccine rates in the US were dismal last year and could look the same this year.
The trial measured the safety, tolerability and effectiveness of Pfizer’s combination vaccine candidates in adults aged 18 to 64. The trial also compared the combination vaccines with an approved flu vaccine and Pfizer’s bivalent Covid vaccine, which targets the BA.4 and BA omicron variants. 5 and the original strain of the virus.
The results showed that the “lead” formulations of Pfizer’s combination vaccine demonstrated strong immune responses to the influenza A, influenza B and Covid strains, according to Pfizer. The safety profiles of the combination vaccine candidates were also in line with the company’s Covid vaccine.
Pfizer and BioNTech are also developing a vaccine that targets both Covid and RSV. Meanwhile, both Moderna and Novavax are developing their own combination plans.